Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients

Clinical Trial ID NCT01059422

PubWeight™ 0.80‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01059422

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Raltegravir in HIV-1 infection: Safety and Efficacy in Treatment-naïve Patients. Clin Med Rev Ther 2011 0.80
Next 100